The role of LncRNAs in tumor immunotherapy

Abbott M, Ustoyev Y. Cancer and the immune system: the history and background of immunotherapy. Semin Oncol Nurs. 2019;35: 150923.

Article  PubMed  Google Scholar 

Ledford H, Else H, Warren M. Cancer immunologists scoop medicine Nobel prize. Nature. 2018;562:20–1.

Article  CAS  PubMed  Google Scholar 

June CH, O’Connor RS, Kawalekar OU, Ghassemi S, Milone MC. CAR T cell immunotherapy for human cancer. Science. 2018;359:1361–5.

Article  CAS  PubMed  Google Scholar 

Lee L, Gupta M, Sahasranaman S. Immune checkpoint inhibitors: an introduction to the next-generation cancer immunotherapy. J Clin Pharmacol. 2016;56:157–69.

Article  CAS  PubMed  Google Scholar 

Vanpouille-Box C, Lhuillier C, Bezu L, Aranda F, Yamazaki T, Kepp O, et al. Trial watch: immune checkpoint blockers for cancer therapy. Oncoimmunology. 2017;6: e1373237.

Article  PubMed  PubMed Central  Google Scholar 

Andrews LP, Yano H, Vignali DAA. Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups. Nat Immunol. 2019;20:1425–34.

Article  CAS  PubMed  Google Scholar 

Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014;15:7–21.

Article  CAS  PubMed  Google Scholar 

Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, et al. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet. 2015;47:199–208.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21:1253–61.

Article  CAS  PubMed  Google Scholar 

Slack FJ, Chinnaiyan AM. The role of non-coding RNAs in oncology. Cell. 2019;179:1033–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu J, Shi A, Long Z, Xu L, Liao G, Deng C, et al. Capturing functional long non-coding RNAs through integrating large-scale causal relations from gene perturbation experiments. EBioMedicine. 2018;35:369–80.

Article  PubMed  PubMed Central  Google Scholar 

Li G, Kryczek I, Nam J, Li X, Li S, Li J, et al. LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy. Nat Cell Biol. 2021;23:526–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Jiang T, Zhou W, Li J, Li X, Wang Q, et al. Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers. Nat Commun. 2020;11:1000.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hon CC, Ramilowski JA, Harshbarger J, Bertin N, Rackham OJ, Gough J, et al. An atlas of human long non-coding RNAs with accurate 5′ ends. Nature. 2017;543:199–204.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Can Res. 2017;77:3965–81.

Article  CAS  Google Scholar 

Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17:47–62.

Article  CAS  PubMed  Google Scholar 

Roth A, Diederichs S. Long noncoding RNAs in lung cancer. Curr Top Microbiol Immunol. 2016;394:57–110.

PubMed  Google Scholar 

Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29:452–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang M, Sun X, Wang H, Xin Y, Jiao W. Long non-coding RNAs in non-small cell lung cancer: functions and distinctions from other malignancies. Transl Cancer Res. 2019;8:2636–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell. 2012;150:12–27.

Article  CAS  PubMed  Google Scholar 

Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science. 2010;329:689–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arshi A, Raeisi F, Mahmoudi E, Mohajerani F, Kabiri H, Fazel R, et al. A comparative study of HOTAIR expression in breast cancer patient tissues and cell lines. Cell J. 2020;22:178–84.

PubMed  Google Scholar 

Chen S, Shen X. Long noncoding RNAs: functions and mechanisms in colon cancer. Mol Cancer. 2020;19:167.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang L, Peng X, Li Y, Zhang X, Ma Y, Wu C, et al. Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma. Mol Cancer. 2019;18:78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun S, Wu Y, Guo W, Yu F, Kong L, Ren Y, et al. STAT3/HOTAIR signaling axis regulates HNSCC growth in an EZH2-dependent manner. Clin Cancer Res. 2018;24:2665–77.

Article  CAS  PubMed  Google Scholar 

Wu XL, Lu RY, Wang LK, Wang YY, Dai YJ, Wang CY, et al. Long noncoding RNA HOTAIR silencing inhibits invasion and proliferation of human colon cancer LoVo cells via regulating IGF2BP2. J Cell Biochem. 2018;120:1221.

Article  PubMed  Google Scholar 

Zhang YF, Li CS, Zhou Y, Lu XH. Effects of propofol on colon cancer metastasis through STAT3/HOTAIR axis by activating WIF-1 and suppressing Wnt pathway. Cancer Med. 2020;9:1842–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang W, Min L, Qiu X, Wu X, Liu C, Ma J, et al. Biological function of long non-coding RNA (LncRNA) Xist. Front Cell Dev Biol. 2021;9: 645647.

Article  PubMed  PubMed Central  Google Scholar 

Pandey GK, Mitra S, Subhash S, Hertwig F, Kanduri M, Mishra K, et al. The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation. Cancer Cell. 2014;26:722–37.

Article  CAS  PubMed  Google Scholar 

Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell. 2010;39:925–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chrousos GP, Kino T. Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Science’s STKE Signal Transduct Knowl Environ. 2005;2005:pe48.

Google Scholar 

Xagorari M, Marmarinos A, Kossiva L, Baka M, Doganis D, Servitzoglou M et al. Overexpression of the GR riborepressor LncRNA GAS5 results in poor treatment response and early relapse in childhood B-ALL. Cancers. 2021; 13.

Kino T, Hurt DE, Ichijo T, Nader N, Chrousos GP. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal. 2010;3:8.

Article  Google Scholar 

Yoon JH, Abdelmohsen K, Srikantan S, Yang X, Martindale JL, De S, et al. LincRNA-p21 suppresses target mRNA translation. Mol Cell. 2012;47:648–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo CJ, Ma XK, Xing YH, Zheng CC, Xu YF, Shan L, et al. Distinct processing of lncRNAs contributes to non-conserved functions in stem cells. Cell. 2020;181(621–636): e622.

Google Scholar 

Ghafouri-Fard S, Dashti S, Farsi M, Taheri M. HOX transcript antisense RNA: an oncogenic lncRNA in diverse malignancies. Exp Mol Pathol. 2021;118: 104578.

Article  CAS  PubMed  Google Scholar 

Zhou JG, Liang B, Liu JG, Jin SH, He SS, Frey B, et al. Identification of 15 lncRNAs signature for predicting survival benefit of advanced melanoma patients treated with anti-PD-1 monotherapy. Cells. 2021;10:977.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu J, Meng Q, Li X, Yang H, Gao N, Sun H, et al. Long noncoding RNA MIR17HG promotes colorectal cancer progression via miR-17-5p. Can Res. 2019;79:4882–95.

Article  CAS  Google Scholar 

Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med. 2012;366:2455–65.

Article  CAS 

留言 (0)

沒有登入
gif